It is for a company like Anavex, but does every investor have a backup plan?
It's good to have a backup plan in your pocket.
Does it feel too late to put one in place for $AVXL, even if some fractional part of biotech portfolio and even more importantly if not?
It is unnecessary because $AVXL is definitely a WGT stock?
If it goes really well with $AVXL, most would probably claim 'see I told you so WGT!' - and what can we say to that other than congratulations!
If trials begin to fail will it be too late for some to learn a lesson of especially biotech investing?
Will there be another opportunity to take substantial $AVXL profit and live with the potential that an even bigger, not return percentage, but absolute return could have been had?
Market Data 
Markets 
AI
